Earnings ·
PACS Group raises full-year Adjusted EBITDA guidance to $685M-$695M on strong Q3 results
PACSPACS Group, Inc.
PACS Group reported third-quarter revenue of $1.50 billion, up 11.5% year-over-year, with net income rising 16.2% to $60.8 million and diluted EPS increasing to $0.37. Adjusted EBITDA grew 33.6% to $175.7 million, driven by a 6.4% same-store revenue increase and improved occupancy of 91.3%. The company also raised its full-year 2026 Adjusted EBITDA guidance to a range of $685 million to $695 million, up from the previous range of $640 million to $660 million, reflecting strong operational performance and contributions from recent acquisitions in Texas and Florida. PACS Group operates one of the largest post-acute healthcare platforms in the United States.